Regulations of ABCB1 and ABCG2 expression through MAPK pathways in acute lymphoblastic leukemia cell lines.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Anticancer Research

• Publication date

  2013-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 24324065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of expression of ABCB1 and LRP genes by mitogen-activated protein kinase/extracellular signal-regulated kinase pathway and its role in generation of side population cells in canine lymphoma cell lines

  2013cited by this paper
• Collagen/β1 integrin signaling up-regulates the ABCC1/MRP-1 transporter in an ERK/MAPK-dependent manner

  2012cited by this paper
• Increased JNK1 Signaling Pathway Is Responsible for ABCG2-Mediated Multidrug Resistance in Human Colon Cancer

  2012cited by this paper
• Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.

  2012cited by this paper
• COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer.

  2011cited by this paper
• Differential expression of FAK and Pyk2 in metastatic and non-metastatic EL4 lymphoma cell lines

  2011cited by this paper
• Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma.

  2011cited by this paper
• Quantitative analysis of mRNA for 10 different drug resistance factors in dogs with lymphoma.

  2010cited by this paper
• Overcoming drug resistance by enhancing apoptosis of tumor cells.

  2009cited by this paper
• CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells.

  2009cited by this paper
• Breast cancer resistance protein/ABCG2 is differentially regulated downstream of extracellular signal‐regulated kinase

  2009cited by this paper
• CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells.

  2009cited by this paper
• Multiple molecular mechanisms for multidrug resistance transporters

  2007cited by this paper
• Expression of Multidrug Resistance 1 (MDR1), Multidrug Resistance-Related Protein 1 (MRP1), Lung Resistance Protein (LRP), and Breast Cancer Resistance Protein (BCRP) Genes and Clinical Outcome in Childhood Acute Lymphoblastic Leukemia

  2007cited by this paper
• Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.

  2006cited by this paper
• Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia.

  2006cited by this paper
• Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease‐free survival

  2004cited by this paper
• Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program

  2003cited by this paper
• Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia.

  2002cited by this paper
• Expression of Functional Markers in Acute Nonlymphoblastic Leukemia

  2001cited by this paper
• Activation of phospholipase C induces the expression of the multidrug resistance (MDR1) gene through the Raf-MAPK pathway.

  2001cited by this paper
• A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A southwest oncology group study

  1995cited by this paper
• Mechanisms of multidrug resistance in cancer treatment.

  1992cited by this paper

• Nbeal2 Inactivation Triggers Abl1 Stabilisation and Dysregulated Subcellular Localisation of the Multi‐Drug‐Resistant Protein MDR1 (ABCB1) in Mast Cells

  2025cites this paper
• Methotrexate resistance and its regulatory mechanisms in pediatric tumors and beyond.

  2025cites this paper
• Effect of ABCB1 Expression on Measurable Residual Disease in Adult Patients with Acute Lymphoblastic Leukemia

  2025cites this paper
• Pretreatment of cancer cells with inhibitors of PKCδ, EGFR, and JNK increased intracellular hypericin content and enhanced the effectiveness of photodynamic therapy.

  2025cites this paper
• Distinguishing acute leukemia subtypes: The role of hsa_circ_0012152 and hsa_circ_0020093 in peripheral blood

  2025influential citation
• Phytochemical intervention in BCRP-driven cancer drug resistance: A comprehensive review.

  2025cites this paper
• Unveiling the Link to ABC Proteins and Epithelial-Mesenchymal Transition in Cancer

  2025cites this paper
• ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target?

  2024cites this paper
• Targeting JNK kinase inhibitors via molecular docking: A promising strategy to address tumorigenesis and drug resistance.

  2024cites this paper
• ATP-binding cassette efflux transporters and MDR in cancer.

  2023cites this paper
• Targeting breast cancer resistance protein (BCRP/ABCG2) in cancer

  2023cites this paper
• Genetics of ABCB1 in Cancer

  2023cites this paper
• Dysregulated Signalling Pathways Driving Anticancer Drug Resistance

  2023cites this paper
• Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia

  2023cites this paper
• Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.

  2022cites this paper
• Meta-analysis of gene signatures and key pathways indicates suppression of JNK pathway as a regulator of chemo-resistance in AML

  2021cites this paper
• UCH-L1 and UCH-L3 regulate the cancer stem cell-like properties through PI3 K/Akt signaling pathway in prostate cancer cells

  2021influential citation
• Multidrug efflux transporter ABCG2: expression and regulation

  2021cites this paper
• Overexpression of Osimertinib-resistant ABCG2 in Non-small cell lung cancer cells

  2021cites this paper
• Potential of B-cell-targeting therapy in overcoming multidrug resistance and tissue invasiveness associated with P-glycoprotein expressing-B cell compartments

  2020cites this paper
• Pathogenesis of pediatric B-cell acute lymphoblastic leukemia: Molecular pathways and disease treatments

  2020cites this paper
• Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.

  2019cites this paper
• How Cancer Cells Resist Chemotherapy: Design and Development of Drugs Targeting Protein-Protein Interactions.

  2019cites this paper
• Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells

  2019cites this paper
• Reversal of P-Glycoprotein and Breast Cancer Resistance Protein Mediated Multidrug Resistance In Vitro Using In Silico Identified Novel Compounds

  2019cites this paper
• SDF-1/CXCR4 axis promotes the growth and sphere formation of hypoxic breast cancer SP cells by c-Jun/ABCG2 pathway.

  2018cites this paper
• Regulation of mPGES-1 composition and cell growth via the MAPK signaling pathway in jurkat cells.

  2018cites this paper
• HIF-1α-induced xenobiotic transporters promote Th17 responses in Crohn's disease.

  2018cites this paper
• In vitro study on reversal of ovarian cancer cell resistance to cisplatin by naringin via the nuclear factor-κB signaling pathway.

  2018cites this paper
• Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on Sarcoma

  2018cites this paper
• A Novel Synthetic Dihydroindeno[1,2-b] Indole Derivative (LS-2-3j) Reverses ABCB1- and ABCG2-Mediated Multidrug Resistance in Cancer Cells

  2018cites this paper
• Ulixertinib (BVD‐523) antagonizes ABCB1‐ and ABCG2‐mediated chemotherapeutic drug resistance

  2018cites this paper
• Secalonic acid D induces cell apoptosis in both sensitive and ABCG2-overexpressing multidrug resistant cancer cells through upregulating c-Jun expression

  2018cites this paper
• Role of P-glycoprotein on CD69+CD4+ cells in the pathogenesis of proliferative lupus nephritis and non-responsiveness to immunosuppressive therapy

  2017cites this paper
• Hypomethylation agent decitabine restores drug sensitivity by depressing P-glycoprotein activity through MAPK signaling pathway

  2017cites this paper
• Inhibition of paclitaxel resistance and apoptosis induction by cucurbitacin B in ovarian carcinoma cells

  2017influential citation
• Discovery of LW6 as a new potent inhibitor of breast cancer resistance protein

  2016cites this paper
• P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SAR & Future Perspective for Drug Design.

  2016cites this paper
• Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.

  2016cites this paper
• In Vitro and In Vivo Regulation of Pro-inflammatory Cytokines and Drug Efflux Transporters by Signal Transduction Pathways in Glial Cells: Implications in HIV-1 Neuropathogenesis and its Treatment

  2015cites this paper
• MEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatment

  2015cites this paper
• Comparative Aspects of Molecular Mechanisms of Drug Resistance through ABC Transporters and Other Related Molecules in Canine Lymphoma

  2015cites this paper
• Glutamate-Mediated Down-Regulation of the Multidrug-Resistance Protein BCRP/ABCG2 in Porcine and Human Brain Capillaries.

  2015cites this paper
• LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2.

  2015cites this paper
• Resveratrol-mediated reversal of tumor multi-drug resistance.

  2015cites this paper
• Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia.

  2015cites this paper
• Role of Breast Cancer Resistance Protein (BCRP, ABCG2) in Cancer Outcomes and Drug Resistance

  2015cites this paper
• ABCG2 regulated by MAPK pathways is associated with cancer progression in laryngeal squamous cell carcinoma.

  2014cites this paper
• The inhibition of ABC transporters in cancer multidrug resistance by heterocyclic cyclohexanone analogues of curcumin

  2014cites this paper
• Multicolor analysis of cell surface marker of human leukemia cell lines using flow cytometry.

  2014cites this paper
• Original Article ABCG2 regulated by MAPK pathways is associated with cancer progression in laryngeal squamous cell carcinoma

  2014cites this paper